Literature DB >> 17498702

Targeted deletion of the osteoclast protein-tyrosine phosphatase (PTP-oc) promoter prevents RANKL-mediated osteoclastic differentiation of RAW264.7 cells.

Jeannie H Yang1, Mehran Amoui, K-H William Lau.   

Abstract

An osteoclastic protein-tyrosine phosphatase, PTP-oc, shares the same gene with a renal PTP, Glepp1. This study demonstrated that targeted deletion of PTP-oc promoter by homologous recombination in RAW264.7 cells completely abolished PTP-oc expression without affecting Glepp1 expression. This strategy to inhibit PTP-oc function has three advantages over commonly used gene knock down strategies (e.g., small interference RNA). This strategy: (1) yielded cells completely devoid of PTP-oc, (2) had no off-target gene silencing effects, and (3) did not affect Glepp1 expression. The inability of PTP-oc-deficient RAW264.7 cells to undergo RANKL-mediated osteoclastic differentiation confirmed a regulatory role for PTP-oc in RANKL-mediated osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498702     DOI: 10.1016/j.febslet.2007.04.063

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.

Authors:  Shira Granot-Attas; Chen Luxenburg; Eynat Finkelshtein; Ari Elson
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

Review 2.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

3.  GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis.

Authors:  Rosanna Pescini Gobert; Monique van den Eijnden; Cedric Szyndralewiez; Catherine Jorand-Lebrun; Dominique Swinnen; Linfeng Chen; Corine Gillieron; Fiona Pixley; Pierre Juillard; Patrick Gerber; Caroline Johnson-Léger; Serge Halazy; Montserrat Camps; Agnes Bombrun; Margaret Shipp; Pierre-Alain Vitte; Vittoria Ardissone; Chiara Ferrandi; Dominique Perrin; Christian Rommel; Rob Hooft van Huijsduijnen
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

4.  Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase.

Authors:  Weidong Geng; Kathy Hill; Joseph E Zerwekh; Thomas Kohler; Ralph Müller; Orson W Moe
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

5.  Targeted transgenic expression of an osteoclastic transmembrane protein-tyrosine phosphatase in cells of osteoclastic lineage increases bone resorption and bone loss in male young adult mice.

Authors:  Matilda H-C Sheng; Mehran Amoui; Virginia Stiffel; Apurva K Srivastava; Jon E Wergedal; K-H William Lau
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

Review 6.  Protein tyrosine phosphatases in skeletal development and diseases.

Authors:  Huiliang Yang; Lijun Wang; Christian Shigley; Wentian Yang
Journal:  Bone Res       Date:  2022-01-28       Impact factor: 13.567

7.  Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.

Authors:  M H-C Sheng; K-H W Lau
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.207

8.  Protein tyrosine phosphatases ε and α perform nonredundant roles in osteoclasts.

Authors:  Eynat Finkelshtein; Sutada Lotinun; Einat Levy-Apter; Esther Arman; Jeroen den Hertog; Roland Baron; Ari Elson
Journal:  Mol Biol Cell       Date:  2014-04-02       Impact factor: 4.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.